By month 12, the distribution of maximum symptom severity significantly shifted toward less severe symptoms in the treatment relative to placebo groups, said Dr. Terri Brown-Whitehorn of @ChildrensPhila at #ACAAI22. @ACAAI @DBVTechnologies #peanutallergy bit.ly/3tAfBdO